Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a privately held medical device company developing a novel, rapid-acting brain stimulation technology designed to treat people suffering from major depressive disorder (MDD) who have not responded to existing treatments. RESTORING MENTAL HEALTH. Depression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression. Our mission is to restore and susta...
We are a privately held medical device company developing a novel, rapid-acting brain stimulation technology designed to treat people suffering from major depressive disorder (MDD) who have not responded to existing treatments. RESTORING MENTAL HEALTH. Depression is caused by identifiable changes in brain networks. We can restore healthy neural activity and relieve symptoms of depression. Our mission is to restore and sustain mental health.

List your booth number for exhibitions, ask us